Reply
- PMID: 34288544
- DOI: 10.1002/acr.24753
Reply
Comment on
-
Efficacy and Safety of Pharmacologic Interventions in Patients Experiencing a Gout Flare: A Systematic Review and Network Meta-Analysis.Arthritis Care Res (Hoboken). 2021 May;73(5):755-764. doi: 10.1002/acr.24402. Arthritis Care Res (Hoboken). 2021. PMID: 32741131 Free PMC article.
-
Efficacy and Safety of Pharmacologic Interventions in Patients Experiencing a Gout Flare: A Systematic Review and Network Meta-analysis. Comment on the Article by Zeng et al.Arthritis Care Res (Hoboken). 2021 Nov;73(11):1698-1699. doi: 10.1002/acr.24755. Epub 2021 Sep 21. Arthritis Care Res (Hoboken). 2021. PMID: 34268912 No abstract available.
References
-
- Qaseem A, Harris RP, Forciea MA. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017;166:58-68.
-
- Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2017;76:29-42.
-
- Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2017;56:1056-9.
-
- Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64:1431-46.
Publication types
LinkOut - more resources
Full Text Sources